Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00701064 · ClinicalTrials.gov registry record · NA

Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)

A NA study of Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT00701064 is a NA study of Posttraumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 71 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00701064, a NA study of Posttraumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.

Interventions

  • OTHER Bright Light Exposure
  • OTHER Negative Ion Generator

Study Locations (1)

Arizona

  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC - Columbia

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2009-01-01
Est. Completion 2019-09-02
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00701064

The ClinicalTrials.gov registry entry for NCT00701064 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (36% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Bright Light Exposure is the first listed.

NCT00701064 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT00701064 about?

NCT00701064 is a clinical study titled "Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)". The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.

What is the current status of trial NCT00701064?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2009-01-01. Estimated completion is 2019-09-02.

What conditions does trial NCT00701064 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT00701064?

The interventions under investigation include: Bright Light Exposure (OTHER), Negative Ion Generator (OTHER).

Who is sponsoring clinical trial NCT00701064?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00701064 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.